Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TREMELIMUMAB\TREMELIMUMAB-ACTL vs TREPROSTINIL DIOLAMINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TREMELIMUMAB\TREMELIMUMAB-ACTL vs TREPROSTINIL DIOLAMINE: Safety Overview

Metric TREMELIMUMAB\TREMELIMUMAB-ACTL TREPROSTINIL DIOLAMINE
Total FAERS Reports 1,173 250
Deaths Reported 328 40
Death Rate 28.0% 16.0%
Hospitalizations 428 136
Average Patient Age 71.1 yrs 55.7 yrs
% Female Patients 18.5% 79.2%
FDA Approval Date N/A Dec 20, 2013
Marketing Status N/A Prescription